Search

Gordon B Dow

from San Francisco, CA
Age ~54
Get Report
Also known as:
Gordon D Dow, Bond Dow Gordon, Dow Gordon
Connected to:
Alexis M Dow, 43Alicia A Dow, 64April L Dow, 53Benny L Dow, 67Betty J Dow, 50Brianna H Dow, 38Brooks E Dow, 36Cabot J Dow, 79Candi L Dow, 52Carrie R Dow, 49

Gordon Dow Phones & Addresses

  • San Francisco, CA
  • 905 113Th St, Seattle, WA 98125
    • s
  • 200 W Comstock St #504, Seattle, WA 98119
  • San Carlos, CA
  • Menlo Park, CA
  • Clyde Hill, WA
  • Kiona, WA

Resumes

Resumes

Gordon Dow Photo 1

Founder And Chief Technology Officer

View page
Location:
1330 Redwood Dr, Petaluma, CA
Industry:
Pharmaceuticals
Work:
Dow Pharmaceutical Sciences
Founder and Chief Technology Officer
Gordon Dow Photo 2

Gordon Dow

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Gordon J. Dow
Dow LLC
Holding Company · Investment Holding Company · Nonclassifiable Establishments
300 Lakeside Dr, Oakland, CA 94612
1111 Polaris Pkwy, Columbus, OH 43240
500 Stanton Christiana Rd, Newark, DE 19713
1500 Grant Ave, Novato, CA 94945
Gordon J. Dow
Harris Abraham, LLC
Investment Holding Company
300 Lakeside Dr, Oakland, CA 94612
Gordon J. Dow
Clindagel, LLC
Pharmaceutical Product · Business Services at Non-Commercial Site
1500 Grant Ave, Novato, CA 94945
4189 Chaparral Ct, Santa Rosa, CA 95409

Publications

Us Patents

Dynamic Dependency Graph In Mvc Paradigm

View page
US Patent:
7464383, Dec 9, 2008
Filed:
Apr 16, 1999
Appl. No.:
09/293737
Inventors:
Gordon B. Dow - Seattle WA, US
Assignee:
Adobe Systems Incorporated - San Jose CA
International Classification:
G06F 3/00
G06F 12/00
US Classification:
719316, 707201
Abstract:
Apparatus and methods for maintaining dependencies among a set of objects in a computer program. Object dependencies are recomputed dynamically when settable object values are changed. Observer-only objects are enqueued for synchronization when marked as invalid. A synchronization process recomputes dependent object values, in the course of which recomputation object dependencies are established according to current object values.

Incremental Update Of Complex Artwork Rendering

View page
US Patent:
8018452, Sep 13, 2011
Filed:
Jun 27, 2007
Appl. No.:
11/769571
Inventors:
Gordon B. Dow - Seattle WA, US
Assignee:
Adobe Systems Incorporated - San Jose CA
International Classification:
G06T 1/00
G09G 5/36
US Classification:
345418, 345684
Abstract:
Methods, systems, and apparatus, including computer program products, for incrementally updating the rendering of an artwork. In one aspect, a method includes first drawing a first portion of an artwork in a view, accepting input to draw a second portion of the artwork in the view, the second portion including a first region and a second region, stopping the first drawing before completion at a first level of completion, second drawing the second region in the view until progress of the second drawing reaches a second level of completion that is approximately the same as the first level of completion, joining the first region and the second region into a third region, and third drawing the third region in the view where the third drawing resumes drawing of the first and second regions at their respective levels of completion.

Topical Antiinflammatory Compositions

View page
US Patent:
47388420, Apr 19, 1988
Filed:
Jan 17, 1986
Appl. No.:
6/819757
Inventors:
Gordon J. Dow - San Rafael CA
Helen J. Schultz - Falcon Heights MN
Assignee:
Riker Laboratories - St. Paul MN
International Classification:
A61U 3178
A61U 3144
US Classification:
424 81
Abstract:
Novel topical creams or lotions containing 2,6-di-t-butyl-4-(2'-thenoyl)phenol exhibiting good skin penetrability are disclosed.

Glyceryl Acetate Ointment Vehicles

View page
US Patent:
50617001, Oct 29, 1991
Filed:
Nov 16, 1989
Appl. No.:
7/438372
Inventors:
Gordon J. Dow - San Anselmo CA
Debra A. Dow - San Rafael CA
International Classification:
A61K 906
A61K 3156
A61K 3157
A61K 3158
US Classification:
514169
Abstract:
Compositions of matter serving as topical ointment vehicles and comprising a glyceryl acetate, preferably triacetin, and an oleaginous material that can be combined with a medicament, preferably a corticosteriod, are described. The glyceryl acetate component functions as a solvent for the medicament. Additionally, methods of use for treating skin disorders comprising the topical application of a therapeutically effective amount of a medicament in a composition of the invention are detailed.

Pharmaceutical Formulations Containing Corticosteroids For Topical Administration

View page
US Patent:
20230088114, Mar 23, 2023
Filed:
Nov 23, 2022
Appl. No.:
17/993806
Inventors:
- Dublin, IE
Gordon DOW - Greenbrae CA, US
International Classification:
A61K 47/14
A61K 31/58
A61K 31/573
A61K 9/06
A61K 9/00
A61K 9/107
A61K 9/127
A61P 17/06
Abstract:
Pharmaceutical compositions for topical application to skin are provided. In some embodiments, the pharmaceutical compositions comprise a corticosteroid and further comprise a liquid oil component comprising one or more dicarboxylic acid esters and/or monocarboxylic acid esters.

Pharmaceutical Formulations Containing Corticosteroids For Topical Administration

View page
US Patent:
20230089309, Mar 23, 2023
Filed:
Nov 23, 2022
Appl. No.:
17/993799
Inventors:
- Dublin, IE
Gordon DOW - Greenbrae CA, US
International Classification:
A61K 47/14
A61K 31/58
A61K 31/573
A61K 9/06
A61K 9/00
A61K 9/107
A61K 9/127
A61P 17/06
Abstract:
Pharmaceutical compositions for topical application to skin are provided. In some embodiments, the pharmaceutical compositions comprise a corticosteroid and further comprise a liquid oil component comprising one or more dicarboxylic acid esters and/or monocarboxylic acid esters.

Topical Pharmaceutical Formulations Containing A Low Concentration Of Benzoyl Peroxide In Suspension In Water And A Water-Miscible Organic Solvent

View page
US Patent:
20230047106, Feb 16, 2023
Filed:
Oct 19, 2022
Appl. No.:
17/969638
Inventors:
- Dublin, IE
Gordon J. Dow - Greenbrae CA, US
Radhakrishnan Pillai - Santa Rosa CA, US
International Classification:
A61K 31/7056
A61K 31/075
A61K 47/10
A61K 8/02
A61K 8/04
A61K 8/34
A61K 8/55
A61K 8/38
A61K 45/06
A61Q 19/00
A61K 9/00
A61K 31/327
A61K 31/235
A61K 9/14
A61K 47/32
Abstract:
An aqueous formulation for topical application to the skin comprising water, a water-miscible organic solvent, and benzoyl peroxide, wherein the concentration of the organic solvent is sufficient to provide a stable suspension of benzoyl peroxide in the aqueous formulation without the inclusion of a surfactant in the formulation, wherein the ratio of concentrations of water and organic solvent in the formulation is sufficient to maintain the benzoyl peroxide in saturated solubility in the formulation following application to the skin, and wherein the concentration of benzoyl peroxide in the formulation is less than 5.0% and at least 1.0% w/w. The formulation may further contain a chemical compound in addition to benzoyl peroxide that is effective in the treatment of acne. The aqueous formulations of the invention are useful in the treatment of acne and acne rosacea.

Anti-Infective Methods, Compositions, And Devices

View page
US Patent:
20210023069, Jan 28, 2021
Filed:
Oct 5, 2020
Appl. No.:
17/062973
Inventors:
- Petaluma CA, US
Gordon Dow - Greenbrae CA, US
International Classification:
A61K 31/454
A61K 47/24
A61K 47/14
A61K 47/10
A61K 47/12
A61K 9/00
A61K 47/06
A61K 47/18
Abstract:
The present invention provides methods for treating onychomycosis. In certain embodiments, the methods comprise comprising applying a pharmaceutically acceptable formulation containing 10% efinaconazole once a day for a treatment period of at least 36 weeks to the treatment area of an onychomycosis patient (a) without debriding the nail or nail-associated tissue initially or during the treatment period and/or (b) without removing the formulation from the treatment area during the treatment period. In certain embodiments, the formulation also comprises, water, cyclomethicone, diisopropyl adipate, alcohol, C12-15 alkyl lactate, butylated hydroxytoluene, citric acid anhydrous, and disodium edetate.
Control profile
Gordon B Dow from San Francisco, CA, age ~54 Get Report